Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2bdcfd5559418dd8dec05a5d25e576ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21b940d68199e364dfe160850ec76145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_215c9e2cb76726b39c35aa5198603cdf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32821280c15c767960d7bed8ba4bde69 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-80 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-80 |
filingDate |
2002-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_addfe371afe8f6619188b1808d02b27a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92190b87d534fe700408dbb8c27c4951 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45bcfb03a8775a3c07e53953e7ca8d9c |
publicationDate |
2002-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-02059623-A2 |
titleOfInvention |
Methods for determining platelet activity with antiplatelet compositions |
abstract |
Methods, compositions and kits are disclosed for the determination of platelet activity on samples such as whole blood that have been affected by exposure to an antiplatelet therapeutic agent such as, e.g., aspiring or a thienopyridine. A combination is provided in a reaction medium wherein the combination comprises the sample and a particle reagent comprising a GP IIb/IIIa receptor ligand such as fibrinogen covalently attached to particles. The medium further comprises a polyhydroxy aromatic compound and a metal cation. The combination is incubated under conditions for agglutinating the particles. The extent of agglutination of the particles is determined and is related to the platelet function activity of the sample. The methods and compositions have particular application to the detection of platelet sensitivity to therapy using aspirin or a thienopyridine and the assessment of the efficacy of such therapy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007537184-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104792982-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005113006-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016320415-A1 |
priorityDate |
2001-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |